September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
HSPG2 mutations identified in black South African children with Primary Congenital Glaucoma
Author Affiliations & Notes
  • Nadia Carstens
    Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, Gauteng, South Africa
  • Saadiah Goolam
    Division of Ophthalmology, Department of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa
  • Susan E I Williams
    Division of Ophthalmology, Department of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa
  • Trevor R Carmichael
    Division of Ophthalmology, Department of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa
  • Scott Hazelhurst
    Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, Gauteng, South Africa
  • Michele Ramsay
    Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, Gauteng, South Africa
  • Footnotes
    Commercial Relationships   Nadia Carstens, None; Saadiah Goolam, None; Susan Williams, None; Trevor Carmichael, None; Scott Hazelhurst, None; Michele Ramsay, None
  • Footnotes
    Support  Postdoctoral support: Fogarty International Center of the National Institutes of Health under Award Number D43 TW008330
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 802. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nadia Carstens, Saadiah Goolam, Susan E I Williams, Trevor R Carmichael, Scott Hazelhurst, Michele Ramsay; HSPG2 mutations identified in black South African children with Primary Congenital Glaucoma. Invest. Ophthalmol. Vis. Sci. 2016;57(12):802.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Primary congenital glaucoma (PCG), a leading cause of childhood blindness worldwide, is a rare developmental autosomal recessive monogenic disorder characterised by trabecular meshwork dysgenesis. Previous linkage studies identified four PCG loci, including two known genes: CYP1B1 and LTBP2. The genetic aetiology of PCG was investigated in 22 black South African PCG cases.

Methods : Whole exome sequencing was done to an average depth of 43x. Using a tiered approach, we first investigated potentially pathogenic variants in the four known PCG loci, then novel or rare homozygous or compound heterozygous mutations with a high probability of functional impact in the rest of the exome. Sixteen genes predicted by Endeavour to have the highest likelihood of impacting the PCG phenotype are discussed.

Results : One boy had a homozygous pathogenic variant (R390H) in CYP1B1 and none of the cases had LTBP2 pathogenic mutations. Eight of the remaining 21 PCG cases had rare, potentially disease causing compound heterozygous variants in the HSPG2 gene, which is located on chromosome 1p36, within a previously identified PCG locus (GLC3B) for which the gene is unknown. A novel HSPG2 G1260A missense mutation was found in the heterozygous state in six of the eight PCG cases in combination with different rare, potentially functional HSPG2 mutations.

Conclusions : Only one of the patients had a mutation in a known PCG gene. We identified potentially disease-causing variants in HSPG2 in eight PCG cases. HSPG2, which encodes perlecan, a microfibril-associated protein involved in cell-adhesion interactions and extracellular matrix integrity, has a reasonable likelihood of impacting the PCG phenotype according to the recently published microfibril hypothesis of glaucoma, which states that defective microfibrils may be an underlying cause of glaucoma. Functional studies are necessary to confirm the effect of perlecan on the PCG phenotype.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×